Trafalgar International, Inc., formerly known as Greater Cannabis Company, Inc., reported its financial results for the second quarter of 2026, revealing a net income of $611,378, a significant turnaround from a net loss of $390,853 in the same period last year. The company did not generate any revenue from product sales or consulting fees during the quarter, maintaining a consistent trend from the previous year. However, the substantial gain on the cancellation of debt, amounting to $621,450, contributed to the positive net income, highlighting a shift in financial performance compared to the prior fiscal period.

In the first half of 2026, Trafalgar also reported a net income of $578,002, compared to a net loss of $633,270 for the same period in 2025. The company’s operating expenses decreased significantly from $91,787 in the first half of 2025 to $44,931 in 2026, primarily due to reduced officer compensation and other operating costs. This reduction in expenses, coupled with the gains from debt cancellation, has improved the company's financial standing, although total revenue remains at zero.

Operationally, Trafalgar has undergone significant changes, including the cancellation and subsequent reissuance of preferred stock, which has altered its capital structure. As of June 30, 2026, the company had 7,628,655 shares of Series A Convertible Preferred stock and 994,379 shares of common stock outstanding. The total stockholders' deficiency improved to $(12,128) from $(741,649) at the end of the previous fiscal year, indicating a positive shift in the company's equity position.

The company’s cash position as of June 30, 2026, was $111, a decrease from $815 at the end of 2025. Current liabilities also saw a reduction, dropping to $12,239 from $742,464, primarily due to the cancellation of debts. Despite these improvements, the company faces ongoing challenges, including the need for additional financing to support its growth plans and the necessity to attract and retain qualified personnel.

Looking ahead, Trafalgar International, Inc. has expressed cautious optimism regarding its future performance, contingent on its ability to navigate the complexities of its operational environment and secure necessary funding. The company acknowledges the inherent risks associated with its business model and market conditions, which could impact its financial results moving forward. As it continues to restructure and refine its operations, the management remains focused on achieving sustainable growth and profitability.

About Greater Cannabis Company, Inc.

The Greater Cannabis Company develops and commercializes cannabinoid therapeutics, focusing on innovative drug delivery platforms and neuropsychiatric treatments. It holds licenses for cannabinoid-based therapies targeting conditions like autism and Parkinson’s disease. The company operates in the medical cannabis sector, emphasizing research, clinical development, and strategic partnerships, with a business model centered on developing proprietary therapeutics and licensing technologies in a highly regulated industry.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov